Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-38.25	-690.85	-499.72
Graham Fair Price	-2.53	0.45	0.46
PEG	11842.97	77.19	0.65
Price/Book	-9.68	13.04	14.44
Price/Cash Flow	-784.95	-948.10	-107.14
Prices/Earnings	12.25	-78.36	-89.30
Price/Sales	-13.62	34.18	39.57
Price/FCF	-784.95	-948.10	-107.14
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	1.25	0.06	0.06
Operating Margin	-2.37	-0.11	-0.11
ROA	-2.16	-0.01	-0.01
ROE	-0.04	-0.04	-2.94
ROIC	-0.02	-0.02	-17.35
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.13	< 0.005	-1496.67
Dividends QOQ	-0.91	12.06	1221.42
EBIT QOQ	0.64	-0.03	-95.56
EPS QOQ	-1.38	0.01	-99.27
FCF QOQ	-2.02	0.90	-55.35
Revenue QOQ	-0.10	< 0.005	-95.54
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	157.45	147.61	-6.24
Days Sales Outstanding (DSO)	177.33	202.97	14.46
Inventory Turnover	0.57	0.61	6.66
Debt/Capitalization	0.59	0.56	-4.30
Quick Ratio	0.65	0.66	2.29
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.49	0.45	-6.56
Cash	0.14	0.10	-29.01
Capex	-0.01	< 0.005	-54.16
Free Cash Flow	-0.07	< 0.005	90.19
Revenue	0.18	0.18	0.45
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.11	1.01	-8.79
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-36.92	-52.94	-43.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating